Cellular Analytics

cellular-analytics.com
Innovation Type:
Diagnostics
Cancer Type:
Multiple
Funding Stage:
Seed
Fund:
Compass Rose
Microfluidic platform and lung cancer biomarker chip used to match patients with the most effective therapy for improved treatment outcomes.

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.